MEDIBANK PRIVATE LIMITED — Director's Dealing 2021

Dec 8, 2021

==> picture [596 x 114] intentionally omitted <==

9 December 2021

Change of Director’s Interest – David Koczkar

In accordance with the Listing Rules, Medibank attaches an Appendix 3Y – Change of Director’s Interest Notice for David Koczkar for release to the market.

This document has been authorised for release by Mei Ramsay, Company Secretary.

Medibank Private Limited ABN 47 080 890 259 GPO Box 9999 Telephone 132 331 medibank.com.au

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity: MEDIBANK PRIVATE LIMITED

ABN: 47 080 890 259

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

f section 205G of the Corporations Act.
Name of Director	David Koczkar
Date of last notice	12 November 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct (Performance Rights pursuant to theMedibank Private Limited Performance RightsPlan (‘Performance Rights Plan’))
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
Date of change	3 December 2021
No. of securities held prior to change	386,968 Performance Rights, being:180,346 Performance Rights granted underthe FY20 Long Term Incentive (LTI); and206,622 Performance Rights granted underthe FY21 LTI.
Class	Performance Rights
Number acquired	821,636 Performance Rights, being:102,787 Performance Rights granted underthe FY21 Deferred Short Term Incentive(Deferred STI); and718,849 Performance Rights granted underthe FY22 LTI.

• See chapter 19 for defined terms.

Appendix 3Y Page 1

01/01/2011

[21 November 2019]

Appendix 3Y Change of Director’s Interest Notice

N	umber disposed	Nil
VNova	alue/Considerationte: If consideration is non-cash, provide details and estimatedluation	Performance Rights granted at nil considerationunder the terms of the Performance Rights Plan.
N	o. of securities held after change	1,208,604 Performance Rights, being:102,787 Performance Rights granted underthe FY21 Deferred STI;
		180,346 Performance Rights granted under
		the FY20 LTI;206,622 Performance Rights granted underthe FY21 LTI; and718,849 Performance Rights granted underthe FY22 LTI.
NExsec	ature of change	Grant of Performance Rights under the
	ample: on-market trade, off-market trade, exercise of options, issue ofurities under dividend reinvestment plan, participation in buy-back	Performance Rights Plan, being the:FY21 Deferred STI; andFY22 LTI.
Di	rect or indirect interest	Indirect
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.
		Indirect interest in Ordinary Shares held viaOlive Man Investments Pty Ltd
Date of change		N/A
No. of securities held prior to change		858,734 Ordinary Shares
Class		Ordinary Shares
Number acquired		Nil
Number disposed		Nil
Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation		N/A
No. of securities held after change		858,734 Ordinary Shares
Nature of changeExample: on-market trade, off-market trade, exercise of options, issueof securities under dividend reinvestment plan, participation in buy-back		N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

[21 November 2019]

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

	2 – Change of director’s interests in contracts	2 – Change of director’s interests in contracts	2 – Change of director’s interests in contracts
	In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.etail of contractN/A
D	etail of contract	N/A
Nature of interest	ature of interest	N/A
Name of registered holder(if issued securities)		N/A
Date of change		N/A
No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to which theinterest has changed		N/A
Interest acquired		N/A
Interest disposed		N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation		N/A
Interest after change		N/A

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed periodwhere prior written clearance was required?	No
If so, was prior written clearance provided toallow the trade to proceed during this period?	N/A
If prior written clearance was provided, on whatdate was this provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 3

01/01/2011